BIOMERIEUX (EPA:BIM)

REGULATED PRESS RELEASE

published on 12/09/2024 at 07:01, 1 year 4 months ago

BIOFIRE® FILMARRAY® Tropical Fever Panel, a syndromic PCR test targeting causes of tropical fever infections, receives U.S. FDA Special 510(k) clearance
bioMérieux receives U.S. FDA Special 510(k) clearance for BIOFIRE® FILMARRAY® Tropical Fever Panel, an innovative PCR test identifying tropical fever pathogens for optimized treatment

BioMérieux Infectious Disease Diagnostics PCR Test Tropical Fever Panel U.S. FDA Clearance
BRIEF

published on 12/05/2024 at 14:02, 1 year 4 months ago

BioMérieux: Details of Share Capital and Voting Rights in November 2024

Share Capital Voting Rights BioMérieux Actions Financial Regulation
BRIEF

published on 11/06/2024 at 09:59, 1 year 5 months ago

Status of bioMérieux Shares and Voting Rights for October 2024

Voting Rights BioMérieux Actions Financial Regulation October 2024
BRIEF

published on 10/30/2024 at 07:06, 1 year 5 months ago

BioMérieux Reports Solid Third-Quarter Performance in 2024

Financial Performance Diagnostic Solutions Sales Growth BioMérieux 2024 GO•28 Strategy
REGULATED PRESS RELEASE

published on 10/30/2024 at 07:01, 1 year 5 months ago

bioMérieux – Third-Quarter 2024 Business Review
bioMérieux reports strong +10.3% organic sales growth, reaching €2,871m in the first nine months of 2024, driven by growth drivers like GO•28 strategic plan and BIOFIRE® respiratory panels. Q3 2024 shows an +11% organic sales growth with confirmation of 2024 full-year revised guidance. CEO Pierre Boulud expresses confidence in achieving targets

BioMérieux Organic Sales Growth 2024 Guidance GO•28 Strategic Plan BIOFIRE Respiratory Panels
BRIEF

published on 10/15/2024 at 07:06, 1 year 6 months ago

BioMérieux Receives CE-Marking for VIDAS® Vitamin B12 Test

BioMérieux Diagnostics Vitamin B12 CE-marking VIDAS®
REGULATED PRESS RELEASE

published on 10/15/2024 at 07:01, 1 year 6 months ago

bioMérieux receives CE-marking for VIDAS® VITAMIN B12 TOTAL, a blood test to measure total Vitamin B12 concentration
bioMerieux announces CE-marking for VIDAS Vitamin B12 Total, an automated blood test to measure total B12 concentration in serum or plasma, aiding in the assessment of B12 status and optimizing patient care

BioMérieux CE-marking VIDAS Vitamin B12 Total Blood Test
BRIEF

published on 10/08/2024 at 10:45, 1 year 6 months ago

Update of the number of shares and voting rights of bioMérieux

Voting Rights BioMérieux Actions Transparency Financial Market
REGULATED PRESS RELEASE

published on 09/05/2024 at 07:01, 1 year 7 months ago

bioMérieux – First-Half 2024 Results
BRIEF

published on 08/06/2024 at 17:39, 1 year 8 months ago

BioMérieux statement on voting rights in July 2024

Voting Rights BioMérieux Actions AMF Financial Informations

Published on 04/21/2026 at 10:00, 1 hour 38 minutes ago

Silver Range Advances the Drum Project in Utah
Published on 04/21/2026 at 09:05, 2 hours 33 minutes ago

Battery X Metals Files International PCT Patent Application for Lithium-Ion Battery Rebalancing Technology, Providing a Pathway to Pursue Patent Protection in 150+ Countries for Technology Validated by a Leading Scientific Institution to Recover ~99% Capa
Published on 04/21/2026 at 05:30, 6 hours 8 minutes ago

Battery X Metals Provides Update on Critical Battery Metals Exploration Initiatives and Portfolio Optimization Strategy
Published on 04/21/2026 at 01:05, 10 hours 33 minutes ago

Boron One Holdings Inc. Announces Closing of Financing
Published on 04/21/2026 at 00:00, 11 hours 38 minutes ago

LIR Life Sciences Corp. Announces Agreement with Resilience BioSciences Inc.

View all ACCESSWIRE

Published on 04/21/2026 at 11:05, 32 minutes ago

Hisense Ignites the Countdown to the FIFA World Cup 2026™, Showcasing Next-Generation Home Entertainment and Smart Living
Published on 04/21/2026 at 11:00, 38 minutes ago

hep global Develops 4.1 MWp Solar Park with Battery Storage in Biessenhofen
Published on 04/21/2026 at 11:00, 38 minutes ago

Promatix Biosciences Highlights the Power of its Logic-Gated Proteomics-Driven Bispecific Discovery Platform to Expand the Tumour-Selective Target Space for Next-Generation ADCs at AACR 2026
Published on 04/21/2026 at 10:30, 1 hour 8 minutes ago

Invitation to the 19th International Investment Forum (IIF) on May 20, 2026 – Digital Focus on Global Growth Stocks
Published on 04/21/2026 at 10:05, 1 hour 32 minutes ago

BrightCharger and Endrich sign licensing agreement to expand BrightZero® charging control to new components and products

View all EQS

Published on 04/21/2026 at 07:00, 4 hours 38 minutes ago

Thales reports its order intake and sales for the first quarter of 2026
Published on 04/21/2026 at 06:59, 4 hours 39 minutes ago

OPmobility - Q1 2026 revenue
Published on 04/20/2026 at 20:44, 14 hours 54 minutes ago

ENGIE - Implementation of share buyback programme
Published on 04/20/2026 at 20:01, 15 hours 37 minutes ago

TERACT - Approval by the AMF of the public buy out offer followed by a squeeze-out of TERACT shares
Published on 04/20/2026 at 17:45, 17 hours 53 minutes ago

Weekly share buyback

View all LES ECHOS COMFI WIRE

News